Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Aantal gebruikers antistolling neemt toe
dec 2025 | Benigne hematologie, Neuro-vasculair, Ritmestoornissen